Method and composition for retarding red blood cell sickling

Details Method and composition for retarding red blood cell sickling Method and composition for retarding red blood cell sickling

1983-03-18

1984-09-25

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

A61K 3578

Patent

active

044735596

ABSTRACT:
A mixture of compositions for reducing red blood cell sickling is disclosed. This process utilizes porphyrinic and chlorophyllic compounds derived from dehydrated legumes and cereal grasses. After processing, the product of interest is a free flowing crystalline solid and has a purple color when dissolved in methanol. It is yellow when dissolved in water, has a strong absorption band near 400 millimicrons when dissolved in either water or methanol and has lesser absorption bands at other wavelengths, is free of esters or ketones and is believed to be an alkali metal salt, the preferred salt being potassium carboxylic acid salt, and wherein the active agent is substantially free of magnesium and includes a trace amount of paramagnetic impurities.

REFERENCES:
patent: 3102891 (1963-09-01), Allen

Affiliated with

Also associated with

Rating

Method and composition for retarding red blood cell sickling does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for retarding red blood cell sickling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for retarding red blood cell sickling will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1769398